ADARx Pharmaceuticals CFO holds 866K-share option

The options vest in stages starting March 24, 2027, with later installments subject to continued service on each vesting date.

Rhea-AI Filing Summary

ADARx Pharmaceuticals, Inc. reported that its CFO and CBO, Ryan Fisk, directly holds an employee stock option covering 865,864 common shares, with an exercise price of $6.31 per share and an expiration date of March 23, 2036. The option was granted March 24, 2026. One-quarter of the shares vest and become exercisable March 24, 2027; the remainder vest in equal quarterly installments thereafter over three years, subject to continued service on each vesting date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Fisk Ryan

Role CFO and CBO

Type	Security	Shares	Price	Value
holding	Employee Stock Option (right to buy) F1	--	--	--

Holdings After Transaction: Employee Stock Option (right to buy) — 865,864 contracts (Direct)

Footnotes (1)

1. F1. Granted to the Reporting Person on March 24, 2026. 1/4 of the total number of shares vest and become exercisable on March 24, 2027 and the remaining shares vest and become exercisable in equal quarterly installments thereafter over a three-year period, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Key Figures

Underlying common shares: 865,864 shares Exercise price: $6.31 per share Grant date: March 24, 2026 +1 more

4 metrics

Underlying common shares 865,864 shares Shares underlying Ryan Fisk's directly held employee stock option

Exercise price $6.31 per share Employee stock option

Grant date March 24, 2026 Employee stock option granted to Ryan Fisk

Expiration date March 23, 2036 Employee stock option

Key Terms

Employee Stock Option (right to buy), vest and become exercisable, equal quarterly installments

3 terms

Employee Stock Option (right to buy) financial

"Employee Stock Option (right to buy)"

vest and become exercisable financial

"shares vest and become exercisable"

equal quarterly installments financial

"vest and become exercisable in equal quarterly installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ADRX option shares does Ryan Fisk report?

Ryan Fisk directly holds an employee stock option covering 865,864 common shares, with an exercise price of $6.31 per share. The option was granted March 24, 2026, and expires March 23, 2036.

When do Ryan Fisk's ADRX options vest?

One-quarter of the option shares vest and become exercisable on March 24, 2027; the remaining shares vest and become exercisable in equal quarterly installments thereafter over a three-year period, subject to Ryan Fisk's continued service on each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/26/2026 - 08:34 PM Accepted by SEC EDGAR 09/24/2026 - 06:36 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Fisk Ryan

(Last) (First) (Middle)

C/O ADARX PHARMACEUTICALS, INC.

5871 OBERLIN DRIVE, SUITE 200

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/24/2026

3. Issuer Name and Ticker or Trading Symbol
ADARx Pharmaceuticals, Inc. [ ADRX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO and CBO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	(1)	03/23/2036	Common Stock	865,864	$6.31	D

Explanation of Responses:

1. Granted to the Reporting Person on March 24, 2026. 1/4 of the total number of shares vest and become exercisable on March 24, 2027 and the remaining shares vest and become exercisable in equal quarterly installments thereafter over a three-year period, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Jiang Bian , Attorney-in-Fact	09/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)